Outpatient treatment of severe peripheral ischemia with intravenous intermittent low-dose iloprost. An open pilot study

International Angiology

Volumn 21, Issue 1, 2002, Pages 36-43

  Banyai, S ^a   Jenelten, R ^a   Wagner, S ^a   Allmann, J ^a   Banyai, M ^a   Koppensteiner, R ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Arterial occlusive diseases; Iloprost; Ischemia, diagnosis; Ischemia, drug therapy; Leg; Treatment outcome

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ILOPROST; LOW MOLECULAR WEIGHT HEPARIN; SODIUM CHLORIDE;

ADULT; AGED; ANALGESIA; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DOSE CALCULATION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG INFUSION; DRUG INTERMITTENT THERAPY; DRUG RESPONSE; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; FLUSHING; FOLLOW UP; FREQUENCY ANALYSIS; GASTROCNEMIUS MUSCLE; HEADACHE; HOSPITAL ADMISSION; HUMAN; LIMB ISCHEMIA; LONG TERM CARE; MALE; NAUSEA AND VOMITING; OUTCOMES RESEARCH; OUTPATIENT CARE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PILOT STUDY; TREATMENT OUTCOME; ULCER HEALING;

AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANGIOPLASTY, BALLOON; BLOOD PRESSURE; COMBINED MODALITY THERAPY; DIABETES COMPLICATIONS; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; ILOPROST; INFUSIONS, INTRAVENOUS; ISCHEMIA; LEG; MALE; MIDDLE AGED; PILOT PROJECTS; PLATELET AGGREGATION INHIBITORS; RECURRENCE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036227261     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Iloprost, a stable prostacyclin derivative, in the treatment of stage IV arterial disease. A placebo controlled multicenter study
2. Iloprost in the treatment of ischemic tissue lesions in diabetics. Results of a placebo-controlled multicenter study with a stable prostacyclin derivative
3. Reduction of ischemic rest pain in advanced peripheral arterial occlusive disease. A double blind placebo controlled trial with iloprost
4. Treatment of limb threatening ischemia with intravenous iloprost: A randomised double-blind placebo-controlled study
5. Treatment of lower limb ischemia due to atherosclerosis in diabetic and non-diabetic patients with iloprost, a stable analogue of prostacyclin: Results of the French multicentre trial
6. Trial of iloprost versus aspirin treatment for critical limb ischemia of thrombangiitis obliterans
7. A metaanalysis of randomized placebo control trials in Fontaine stages III and IV peripheral occlusive arterial disease
8. Low-dose iloprost infusions compared to the standard dose in patients with peripheral arterial occlusive disease Fontaine stage IV
9. Ischaemic necrotic toes associated with antiphospholipd syndrome and treated with iloprost
10. Use of prostacyclin analogue in cholesterol crystal embolism
11. Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study
12. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers to systemic sclerosis
13. A double blind, randomised, multi-centre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases
14. Iloprost and Cisaprost for Raynaud's phenomenon in progressive systemic atherosclerosis
15. Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis
16. Treatment of patients with peripheral arterial occlusive disease in Fontaine stages III and IV with intravenous iloprost: An open study in 900 patients
17. Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE: A randomized open controlled study
18. Iloprost. A review of its pharmacodynamic and pharmaco kinetic properties, and therapeutic potential on peripheral vascular disease, myocardial ischemia and extracorporeal circulation procedures
19. Iloprost in der Behandling ischämischer Gewebslasionen bei Diabetikern
20. Evaluation of a conservative treatment with iloprost in severe peripheral occlusive arterial disease (PAOD)